PEG-IFN Improves Responses to Dasatinib in Newly Diagnosed CML Patients

Safety and efficacy of the combination of pegylated interferon-α2b and dasatinib in newly diagnosed chronic phase chronic myeloid leukemia patients

The addition of pegylated interferon-ɑ2b (PegIFN) to the tyrosine kinase inhibitor (TKI) dasatinib yielded promising results in 40 newly diagnosed chronic myeloid leukemia (CML) patients. At the 3-month mark prior to initiation of PegIFN, 10% of patients achieved a major molecular response (MMR) and 66% achieved a complete cytogenetic remission (CCgR). The results published in Leukemia suggest that combining dasatinib with PegIFN may increase the chance of achieving long-standing treatment-free remission. (Read full publication…)

Advanced BioChemicals (ABC) offer various high quality linear and multi-arm PEG products with a broad range of molecular weight. We also offer custom synthesis service to support your research. We have increased in stock of inventories, please contact us for free quotation and detail.

May Promotions:

5% Off discount on all mPEG products until May 31, 2016.

Advanced BioChemicals (ABC) greatly appreciate your business and support. In order to feedback your supports, $5, $10, $15, $20 and $40 Amazon gift card will be shipped with your order when the amount reaches $0-$200, $200-$500, $500-$750, $750-$1000 and over $1000, respectively.